CGA
CAH icon

Crescent Grove Advisors’s Cardinal Health CAH Stock Holding History

Crescent Grove Advisors’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,140
Closed -$294K – 266
2022
Q1 		$294K Buy
5,140
+645
+14% +$34.5K 0.03% 231
2021
Q4 		$234K Buy
+4,495
New +$220K 0.02% 267

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crescent Grove Advisors's CAH Position: Q2 2022 in Review

Crescent Grove Advisors sold out of Cardinal Health (CAH) in Q2 2022, closing a stake of 5,140 shares — an estimated $294K sold.

Crescent Grove Advisors first reported a position in CAH in Q4 2021 and held it in 2 quarters. The position peaked at $294K in Q1 2022. 792 funds tracked by Wall St. Rank hold CAH as of Q2 2022.

  • Crescent Grove Advisors reported no remaining Cardinal Health position as of Q2 2022 after selling out during the quarter.
  • Crescent Grove Advisors sold 5,140 Cardinal Health shares in Q2 2022, an estimated $294K.
  • Crescent Grove Advisors first reported a position in Cardinal Health in Q4 2021 and held it in 2 quarters.
  • Crescent Grove Advisors's Cardinal Health position peaked at $294K in Q1 2022.
  • 792 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2022.

Based on Crescent Grove Advisors's 13F filing for Q2 2022, filed 20 Jul 2022.